Data Foundry

Drug recalls 2026

norepinephrine Bitartrate — Class II drug recall D-0438-2026

Ongoing recall by Fagron Compounding Services, reported 2026-04-15, distributed nationwide. Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port

Recall numberD-0438-2026
Product typeDrug
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmFagron Compounding Services, Wichita, KS, United States
Recall initiated2026-03-20
Classified2026-04-07
Reported by FDA2026-04-15
DistributedNationwide (US)
Quantity25,260 bags
Reason classessterility, device malfunction
NDC71266-5026-02
Lot numbersC274-000049934, C274-000049963, C274-000050074, C274-000050123, C274-000050296, C274-000050420, C274-000050774, C274-000050924, C274-000050961, C274-000050991, C274-000051139, C274-000051166, C274-000051198, C274-000051343
Expiration dates2026-04-23, 2026-04-24, 2026-04-30, 2026-05-01, 2026-05-09, 2026-05-16, 2026-06-05, 2026-06-11, 2026-06-12, 2026-06-19, 2026-06-20, 2026-06-21, 2026-06-28

Product

norepinephrine Bitartrate,16mg per 250mL 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5026-02

Reason for recall

Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0438-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.